Natco Pharma raises stake in South Africa’s Adcock Ingram to 49%
Natco Pharma has increased its stake in the South African pharmaceutical company Adcock Ingram to 49% through a transaction worth approximately ₹1,060 crore. This move is part of the Indian company's long-term strategy to expand its footprint in the African healthcare market.
Why it matters
This acquisition reflects the growing trend of Indian pharmaceutical companies expanding their international presence through strategic investments in emerging markets.
Generic drugmaker Natco Pharma has completed the acquisition of an additional 13.25% stake in South African pharmaceutical and healthcare company Adcock Ingram Holdings Proprietary.
The article is a straightforward business report on a corporate acquisition.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in